125511-47-9

Upstream product

• 556-02-5 ?Tyr 
• 71-36-3 butan-1-ol 
• 60-18-4 L-tyrosine 

Downstream Products

• 1027260-72-5 (S)-2-[(1-tert-Butoxycarbonylamino-cyclopentanecarbonyl)-amino]-3-(4-hydroxy-phenyl)-propionic acid butyl ester 
• 169319-70-4 (S)-2-{[1-((S)-2-Acetylsulfanyl-3-methyl-butyrylamino)-cyclopentanecarbonyl]-amino}-3-(4-hydroxy-phenyl)-propionic acid butyl ester 
• 169319-98-6 (S)-3-(4-Hydroxy-phenyl)-2-{[1-((S)-2-mercapto-3-methyl-butyrylamino)-cyclopentanecarbonyl]-amino}-propionic acid butyl ester 

Relevant academic research and scientific papers

First Total Synthesis of the Marine-Derived Anti-inflammatory Natural Product (-)-Herdmanine D through a Steglich Esterification

An efficient and regioselective route for the first total synthesis of the antiinflammatory marine natural product ( )-herdmanine D, with an excellent overall yield of 18%, is described. A key feature of the synthetic strategy is a Steglich esterification of regioselectively constructed 6-bromo-5-methoxy-1H-indole-3-carboxylic acid with protected L-tyrosine. The formation of the L-isomer was confirmed through measurement of the optical activity. The current strategy paves the way for the construction of diverse analogues of ( )-herdmanine D for drug development.

Phospholipid gel compositions for delivery of aptamers and methods of treating conditions using same

The present invention relates to pharmaceutical compositions in the form of a gel for controlled- or sustained-release of an aptamer and to methods for treating or preventing a condition in an animal by administering to an animal in need thereof the pharm

Pharmaceutical compositions for the administration of aptamers

Pharmaceutical compositions comprising an aptamer and an amino acid ester or amide or an aptamer; a divalent metal cation; and a carboxylic acid, a phospholipid, a phosphatidyl choline, or a sphingomyelin. Methods of treating or preventing a condition in

Compositions for controlled delivery of pharmaceutically active compounds

The invention relates to pharmaceutical compositions that provide sustained-release of a pharmaceutically active compound and to methods of treating or preventing a condition in an animal by administering the pharmaceutical compositions to the animal by i